Skip to content

Innoviva, Inc. INVA Change in Prepaids

Change in Prepaids at other companies

ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$2.69M-168%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
-$4.31M-128%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.4B+9.7%
P/E3.5×
P/S4.1×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s change in prepaids.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s change in prepaids?
Innoviva, Inc. (INVA) reported change in prepaids of -$1.88M in Q1 2026.
How has Innoviva, Inc.'s change in prepaids changed year-over-year?
Innoviva, Inc.'s change in prepaids increased by 66.7% year-over-year, from -$5.65M to -$1.88M.
What does change in prepaids mean?
This represents the net change in payments made in advance for goods or services to be received in future periods. An increase in prepaid expenses consumes cash, while a decrease serves as a source of cash. It is a key indicator of working capital management and timing of operational expenditures.